Canaccord Adams Says Cell Genesys (CEGE) Will Have Partner By Mid-'08
Tweet Send to a Friend
Canaccord Adams reiterates it Buy rating and $7.70 price target on Cell Genesys (Nasdaq: CEGE).
This article: 74 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 74 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
